Elicio Therapeutics (ELTX) PT Raised to $17.50 at Rodman & Renshaw Jun 15, 2026 09:46AM
Rodman & Renshaw Starts Kyntra Bio (KYNB) at Buy Jun 9, 2026 07:01AM
Rodman & Renshaw Starts Neurogene (NGNE) at Buy, PT $70 Jun 3, 2026 06:42AM
Rodman & Renshaw Starts Bolt Biotherapeutics, Inc. (BOLT) at Buy May 28, 2026 04:17PM
Rodman & Renshaw Starts Sana Biotechnology (SANA) at Buy, PT $16 May 11, 2026 07:31AM
View Older Stories

Apr 15, 2026 08:08AM Rodman & Renshaw Starts TuHURA Biosciences (HURA) at Buy
Apr 14, 2026 06:31AM Rodman & Renshaw Starts CAMP4 Therapeutics Corp (CAMP) at Buy
Apr 2, 2026 06:31AM Rodman & Renshaw Starts SAB Biotherapeutics (SABS) at Buy
Mar 17, 2026 07:57AM Rodman & Renshaw Starts BioXcel Therapeutics (BTAI) at Buy, PT $17
Mar 9, 2026 04:16PM Rodman & Renshaw Starts Karyopharm Therapeutics (KPTI) at Buy, PT $28
Mar 9, 2026 04:16PM Rodman & Renshaw Starts Elicio Therapeutics (ELTX) at Buy
Jan 23, 2026 04:09PM Soligenix enters agreement to sell up to $3.45 million in stock
Jan 20, 2026 07:36AM Rodman & Renshaw Starts Beyond Air (XAIR) at Buy
Jan 13, 2026 07:20AM Rodman & Renshaw Starts Telomir Pharma (TELO) at Buy
Jan 13, 2026 07:20AM Rodman & Renshaw Starts Ascentage Pharma Group (AAPG) at Buy
Jan 13, 2026 07:19AM Rodman & Renshaw Starts Biomea Fusion Inc. (BMEA) at Buy
Jan 13, 2026 07:19AM Rodman & Renshaw Starts BioAtla Inc. (BCAB) at Buy
Jan 13, 2026 07:19AM Rodman & Renshaw Starts Jasper Therapeutics (JSPR) at Buy
Nov 25, 2025 02:42PM Scilex raises $20.3 million through warrant exercise
Nov 24, 2025 06:01AM Scilex raises $20.3 million through warrant exercise agreement
Nov 6, 2025 08:50AM Fitell secures $50 million convertible note financing for robotics venture
Oct 16, 2025 04:05PM MIRA Pharmaceuticals sells 1.75M shares at 66% premium
Oct 10, 2025 05:16PM Bluejay Diagnostics closes $4.5 million private placement
Oct 10, 2025 05:16PM Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Oct 9, 2025 03:15PM Bluejay Diagnostics raises $4.5 million in private placement
Oct 9, 2025 03:15PM Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Sep 23, 2025 09:10AM Fitell launches $100M Solana treasury strategy with DeFi focus
Sep 2, 2025 01:38PM Actelis Networks raises $1.6 million through warrant exercise
Jul 1, 2025 07:00AM Banzai International (BNZI) Secures $11M in Debt Financing
Apr 24, 2025 08:00AM Kairos Pharma (KAPA) Issues Letter to Stockholders
Apr 24, 2025 08:00AM Kairos Pharma Ltd. Provides Letter to Stockholders
Mar 25, 2025 12:35PM Rodman & Renshaw Reiterates Buy Rating on CorMedix (CRMD), PT $20, 'weakness today is likely overdone'
Mar 25, 2025 10:05AM Rodman & Renshaw Reiterates Sell Rating on Cassava Sciences (SAVA), PT $2
Mar 10, 2025 12:23PM Trevi Therapeutics (TRVI) PT Raised to $20 at Rodman & Renshaw
Mar 4, 2025 10:26AM Rodman & Renshaw Reiterates Buy Rating on Compugen (CGEN)
Mar 4, 2025 09:59AM Rodman & Renshaw Reiterates Buy Rating on Adial Pharmaceuticals Inc (ADIL)
Mar 3, 2025 03:36PM BioXcel Therapeutics (BTAI) announces direct offering of $14 million
Feb 25, 2025 09:45AM Rodman & Renshaw Reiterates Buy Rating on Bicycle Therapeutics (BCYC)
Feb 20, 2025 04:08PM Rodman & Renshaw Starts Telomir Pharma (TELO) at Buy
Feb 10, 2025 08:45AM Fitell Corporation (FTEL) Announces Updated Registered Direct Offering for up to $10.0 Million
Feb 7, 2025 08:00AM Fitell Corporation (FTEL) Announces $10.0 Million Registered Direct Offering
Feb 3, 2025 03:20PM GH Research PLC (GHRS) PT Raised to $42 at Rodman & Renshaw
Jan 28, 2025 06:45AM Rodman & Renshaw Starts Cardiol Therapeutics (CRDL) at Buy
Jan 28, 2025 06:45AM Rodman & Renshaw Starts Indivior (INDV) at Buy
Jan 28, 2025 06:44AM Rodman & Renshaw Starts Rein Therapeutics (RNTX) at Buy
Jan 28, 2025 06:44AM Rodman & Renshaw Starts PolyPid Ltd. (PYPD) at Buy
Jan 28, 2025 06:43AM Rodman & Renshaw Starts Talphera (TLPH) at Buy
Jan 28, 2025 06:31AM Rodman & Renshaw Starts INmune Bio Inc. (INMB) at Buy
Jan 27, 2025 06:58AM Compass Pathways (CMPS) PT Lowered to $9 at Rodman & Renshaw
Jan 21, 2025 08:32AM Kairos Pharma (KAPA) Provides Business Update and Outlook into 2025
Jan 21, 2025 08:30AM Kairos Pharma Provides Business Update and Outlook into 2025
Dec 20, 2024 06:42AM Rodman & Renshaw Starts Atara Biotherapeutics (ATRA) at Buy
Dec 19, 2024 05:48AM Rodman & Renshaw Starts TuHURA Biosciences (HURA) at Buy
Dec 18, 2024 01:02PM BioMedNewsBreaks — Kairos Pharma, Ltd. (NYSE: KAPA) Receives ‘Buy’ Recommendation, $12.00 Price Target in Rodman & Renshaw Research Report
Dec 11, 2024 04:08PM Rodman & Renshaw Starts FibroBiologics (FBLG) at Buy
View Older Stories